INVENTIVA (EPA:IVA) | Finanzwire

PRESS RELEASE

published on 05/22/2025 at 14:00, 10 months 5 days ago

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux
Inventiva implements share repurchase program with Kepler Chevreux under liquidity agreement approved by Ordinary General Meeting. Program details and objectives announced for 18-month period

Liquidity Agreement Ordinary General Meeting Share Repurchase Program Inventiva Kepler Chevreux
BRIEF

published on 05/15/2025 at 14:31, 10 months 12 days ago

Crossing thresholds at INVENTIVA

Voting Rights Capital Capital Increase Crossing Thresholds Inventiva
BRIEF

published on 05/15/2025 at 14:30, 10 months 12 days ago

Threshold crossing by Invus at INVENTIVA

Capital Increase Threshold Crossing Shares And Voting Rights Inventiva Invus Public Equities
BRIEF

published on 05/13/2025 at 11:29, 10 months 14 days ago

Crossing of thresholds by Samsara BioCapital in INVENTIVA

Warrants Capital Increase Crossing Thresholds Inventiva Samsara BioCapital
PRESS RELEASE

published on 05/05/2025 at 08:30, 10 months 22 days ago

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
BRIEF

published on 04/24/2025 at 22:06, 11 months 2 days ago

Inventiva Unveils New Biomarker Analysis for MASH Treatment

Lanifibranor MASH Treatment Biomarker Signatures Histological Response Predictive Accuracy
PRESS RELEASE

published on 04/24/2025 at 22:01, 11 months 2 days ago

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
Inventiva announces publication in Clinical Gastroenterology and Hepatology of non-invasive biomarker signatures predictive of histological response in MASH patients treated with lanifibranor

Inventiva Lanifibranor Biomarker Signatures Histological Response Clinical Gastroenterology
BRIEF

published on 04/15/2025 at 22:05, 11 months 11 days ago

Inventiva Files 2024 Financial Documents with Regulatory Agencies

Biopharmaceutical Regulatory Filing Inventiva MASH 2024 Financials
PRESS RELEASE

published on 04/15/2025 at 22:00, 11 months 11 days ago

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
Inventiva files its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F with the AMF and SEC. Documents accessible on Inventiva's website and regulatory authorities' sites

2024 Form 20-F Registration Document Clinical-Stage Biopharmaceutical Inventiva
BRIEF

published on 03/26/2025 at 21:05, 1 year ago

Inventiva unveils its 2024 financial results and strategic projects

Strategic Reorganization 2024 Financial Results Research & Development Lanifibranor Structured Financing

Published on 03/27/2026 at 12:30, 2 hours 5 minutes ago

Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 2 hours 35 minutes ago

Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 12:00, 2 hours 35 minutes ago

Athena Gold Announces Share Consolidation
Published on 03/27/2026 at 11:00, 3 hours 35 minutes ago

RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 5 hours 5 minutes ago

Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area

View all ACCESSWIRE

Published on 03/27/2026 at 14:28, 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 03/27/2026 at 14:28, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/27/2026 at 14:27, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Published on 03/27/2026 at 14:26, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 03/27/2026 at 14:25, 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc

View all EQS

Published on 03/26/2026 at 18:17, 20 hours 18 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 20 hours 50 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 1 day 5 hours ago

Edenred statement
Published on 03/26/2026 at 07:30, 1 day 7 hours ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 1 day 19 hours ago

LNA SANTE : 2025 Annual Results

View all LES ECHOS COMFI WIRE

News